US Stocks
/
Phathom Pharmaceuticals, Inc. Share Price
Phathom Pharmaceuticals, Inc. Share Price

Phathom Pharmaceuticals, Inc. Share Price

NASDAQ: PHAT | Small Cap
$7.12
+$0.30 (4.48%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Phathom Pharmaceuticals, Inc. Stock Performance

Open
$6.75
Prev. Close
$6.82
Circuit Range
N/A
Day Range
$6.70 - $7.17
Year Range
$6.54 - $18.25
Volume
59,512
Average Traded
$7.04

Phathom Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Phathom Pharmaceuticals, Inc.'s share price is $7.12. The stock opened at $6.75, compared to its previous close of $6.82. During today's trading session, Phathom Pharmaceuticals, Inc.'s share price traded between $6.70 and $7.17, with an average price of $6.94. Over the past 52 weeks, the stock has recorded a high of $18.25 and a low of $6.54. In terms of performance, Phathom Pharmaceuticals, Inc.'s share price has declined by 36.11% over the last six months and is down 47.49% on a year-on-year basis.

Phathom Pharmaceuticals, Inc. Share Price Chart

$6.70$7.17
L
Show Current Price
H

Phathom Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$519.18M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.22
Revenue (TTM)
$175.11B
Return On Equity (TTM)
28.78%
Profit Margin
-126.35%
Debt to Equity
-0.48
Quarterly Earnings Growth YoY
41.34%

Phathom Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$49.50$57.58$58.30$74.27
Net Profit-$29.97-$21.15-$30.37-$17.58
Net Profit Margin-60.55%-36.73%-52.09%-23.67%
Income ChangeN/A29.43%-43.59%42.11%

Phathom Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.68$55.25$175.11
Net Profit-$197.72-$201.59-$334.33-$221.25
Net Profit MarginN/A-29645.59%-605.12%-126.35%
Income ChangeN/A-1.96%-65.85%33.82%

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Phathom Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$7.26
$7.13
-2.53%
Sep 2026
$9.62
$7.32
-18.07%
Aug 2026
$8.71
$8.94
+0.56%
Jul 2026
$10.91
$8.88
-18.19%
Jun 2026
$9.57
$10.86
+13.12%
May 2026
$11.44
$9.60
-13.86%
Apr 2026
$11.29
$11.14
+0.13%
Mar 2026
$12.09
$11.13
-11.42%
Feb 2026
$13.83
$12.56
-8.15%
Jan 2026
$16.52
$13.68
-17.59%
Dec 2025
$15.33
$16.60
+5.87%
Nov 2025
$13.51
$15.68
+15.63%

PHAT Share Price FAQs

What is Phathom Pharmaceuticals, Inc. share price today?

chevron-up
Phathom Pharmaceuticals, Inc. share price today is $7.12 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Phathom Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Phathom Pharmaceuticals, Inc. stock is $18.25, while the 52 week low is $6.54 as of 9 Oct '26.

What is PHAT's market capitalisation today?

chevron-up
PHAT market capitalisation is $519.18M as of October 9, 2026, at 5:16 am IST.

What is PHAT's net income for the last quarter?

chevron-up
PHAT's net income for the last quarter is -17.58B USD.

What is the 5 year returns of PHAT?

chevron-up
The 5 year returns of PHAT is -69.74% as on 9 Oct '26.

What is the high & low stock price of PHAT today?

chevron-up
PHAT stock price hit a high of $7.17 and low of $6.70 as of 9 Oct '26.

Can I buy PHAT shares in India?

chevron-up
Yes. You can buy PHAT in India by opening an international trading account.